Skip to main content
Clinical Trials/NCT01869842
NCT01869842UnknownNot Applicable

Randomized Controlled Study of the Traditional Percutaneous Coronary Intervention and Intervention Using Optical Coherence Tomography of Incomplete Stent Adhesion and Extent of the Formation of Neointima by Resolute Zotarolimus-eluting Stent Insertion

Yonsei University1 site in 1 country115 target enrollmentStarted: December 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
115
Locations
1
Primary Endpoint
ratio of the stent strut

Study Overview

Brief Summary

Optical coherence tomography (OCT) after the stent procedure to improve the adhesion and expansion, or incomplete uncovered struts attached to the main track. OCT in clinical areas by improving the parameters of the best stent will be useful. However, for better results for optical coherence tomography in percutaneous interventions have little useful data on the role. Randomized controlled study of the traditional percutaneous coronary intervention and intervention using optical coherence tomography.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Single lesion in a Single vessel
  • •Reference vessel diameter 2.5 - 3.5 mm
  • •Lesion length ≤ 34 mm and ≤ 34 mm stent length
  • •Stable angina requiring revascularization, patients with unstable angina
  • •The patient has no difficulty to enforce the follow-up angiography
  • •Patient is ≥ 20 years old

Exclusion Criteria

  • •Lesions with graft vessel, thrombosis, restenosis, and bifurcation requiring 2 stents
  • •Reference vessel diameter < 2.5 mm or > 4.0mm
  • •Contraindication to anti-platelet agents
  • •Treated with any DES within 3 months at other vessel
  • •Creatinine level ≥ 2.0 mg/dL or ESRD
  • •Severe hepatic dysfunction (3 times normal reference values)
  • •Patients with LVEF < 30%
  • •Life expectancy 1 year
  • •Lesions with CTO or left main
  • •Target vessel of ST-elevation MI
  • •Lesions requiring overlapped stenting or more than 2 DES in each vessel
  • •Heavy calcified lesions (definite calcified lesions on angiogram)
  • •Far distal or tortuous lesions having difficulties in OCT evaluation or follow-up OCT
  • •Pregnant women or women with potential childbearing

Arms & Interventions

DM, angio group

Active Comparator

Intervention: percutaneous coronary intervention (Procedure)

DM, OCT group

Experimental

Intervention: OCT-guided percutaneous coronary intervention (Procedure)

non DM, angio group

Active Comparator

Intervention: percutaneous coronary intervention (Procedure)

non DM, OCT group

Experimental

Intervention: OCT-guided percutaneous coronary intervention (Procedure)

Outcomes

Primary Outcomes

ratio of the stent strut

Time Frame: Angiographic follow-up with OCT at 6 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials